govt.chinadaily.com.cn

News and Policies

COVID-19 vaccine commercial production plant put into use in Yantai

Updated: Dec 16, 2021 chinadaily.com.cn Print
Share - WeChat
The commercial production plant in Yantai has an annual production of 1 billion doses of COVID-19 vaccines. [Photo/WeChat account: yantaifabu]

A commercial production plant for COVID-19 vaccines was put into use in Yantai, a coastal city of Shandong province on Dec 1.

Operated by the Luye Life Sciences Group, the plant has an annual production capacity of 1 billion doses of vaccines. It is also Shandong's first VLP vaccine commercial production facility.

The 21,000-square-meter plant will mainly produce the LYB001 COVID-19 vaccine.

The plant is able to boost its production capacity to 2 billion doses or higher and support overseas clinical research and commercial production.

Copyright©2024 China Daily. All rights reserved.

京ICP备13028878号-6

京公网安 京公网安备 11010502032503号